Ascend Gene & Cell Therapies
UKEntry
2023
Hold
3yr
Status
Active
Who owns Ascend Gene & Cell Therapies?
Ascend Gene & Cell Therapies is currently owned by Abingworth through Abingworth Bioventures 8 (2021 vintage), since 2023.
Hand-verified · updated 2026-05-21
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Ascend Gene & Cell Therapies
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Ascend Gene & Cell Therapies?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Ascend Gene & Cell Therapies.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue